Author

M. Nieuwland

h-index 20 View on Semantic Scholar

We have 3 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.

Mature overall survival (OS) and updated progression-free survival (PFS) outcomes and an in-depth biomarker analysis are reported and highlighted CD8+PD1+ T-cells as candidate biomarkers in relation to clinical benefit from immune checkpoint blockade in advanced PeSCC.

T. Rafael, Alberto Gil-Jimenez, L. Elst et al. · Cancer immunology research · 0 citations

Open access Sep 2026

A spatial single-cell transcriptomic atlas of metastatic breast cancer progression

A unique single-cell spatial framework on metastatic breast cancer development and progression is presented, in a highly complex systemic treatment landscape.

Z. Dauyey, A. Velds, R. Gobits et al. · medRxiv · 0 citations

Open access Aug 2026

Proteomics of human cancer-associated T cells identifies regulators of T cell functionality

Integrated multi-omic profiling of human tumor-infiltrating T cells reveals cell-intrinsic regulators of T cell dysfunction that are missed by transcriptomic analyses alone, highlighting an additional layer of regulatory control.

Kaspar Bresser, Zan Hozjan, N. Servaas et al. · bioRxiv · 0 citations